Mitomycin C is a natural antitumor antibiotic used in clinical cancer chemotherapy. The broad, long-term objective of the present application is to utilize the recently obtained, detailed information on the structural basis of the bioreductive DNA-alkylating activity of mitomycin C for designing new mitomycin analogs with improved antitumor properties. The designs aim at constructing drugs which will retain the basic reductive bifunctional alkylation mechanism of mitomycin C but will be more efficient as cross-linkers. The new mitomycin analogs will be synthesized by relatively simple chemical transformations of mitomycins A or C. They will be tested for reductive alkylation and cross-linking of DNA and for DNA sequence specificity of the modifications. In addition, the structures of the DNA adducts will be investigated. Cytotoxicity of the new agents to a variety of tumor cells will be determined and a correlation will be sought between their DNA cross-linking activity, measured by alkaline elution in EMT mouse mammary tumor cells, and their cytoxicity. Concomitant and interactive with the design efforts, mechanistic investigations of mitomycin C will continue with respect to DNA alkylation in vitro, basis of the CpG specificity of the cross-link and the """"""""self-reducing"""""""" activity of certain mitomycin C analogs, inducible by thiols. An investigation of repair of model oligonucleotide substrates containing mitomycin adducts by a purified mammalian repair enzyme will be initiated.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Virology Study Section (VR)
Program Officer
Wong, May
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pittsburgh
Schools of Arts and Sciences
United States
Zip Code
Rathi, Abhilasha V; Cantalupo, Paul G; Sarkar, Saumendra N et al. (2010) Induction of interferon-stimulated genes by Simian virus 40 T antigens. Virology 406:202-11
Cantalupo, Paul G; Sáenz-Robles, Maria Teresa; Rathi, Abhilasha V et al. (2009) Cell-type specific regulation of gene expression by simian virus 40 T antigens. Virology 386:183-91
Pipas, James M (2009) SV40: Cell transformation and tumorigenesis. Virology 384:294-303
Ahuja, Deepika; Rathi, Abhilasha V; Greer, Amy E et al. (2009) A structure-guided mutational analysis of simian virus 40 large T antigen: identification of surface residues required for viral replication and transformation. J Virol 83:8781-8
Wright, Christine M; Chovatiya, Raj J; Jameson, Nora E et al. (2008) Pyrimidinone-peptoid hybrid molecules with distinct effects on molecular chaperone function and cell proliferation. Bioorg Med Chem 16:3291-301
Zhao, Xiaorong; Madden-Fuentes, Ramiro J; Lou, Becky X et al. (2008) Ataxia telangiectasia-mutated damage-signaling kinase- and proteasome-dependent destruction of Mre11-Rad50-Nbs1 subunits in Simian virus 40-infected primate cells. J Virol 82:5316-28
Saenz-Robles, M T; Toma, D; Cantalupo, P et al. (2007) Repression of intestinal drug metabolizing enzymes by the SV40 large T antigen. Oncogene 26:5124-31
Ahuja, Deepika; Saenz-Robles, M Teresa; Pipas, James M (2005) SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 24:7729-45
Cantalupo, Paul; Doering, Adrienne; Sullivan, Christopher S et al. (2005) Complete nucleotide sequence of polyomavirus SA12. J Virol 79:13094-104
Markovics, Jennifer A; Carroll, Patrick A; Robles, M Teresa Saenz et al. (2005) Intestinal dysplasia induced by simian virus 40 T antigen is independent of p53. J Virol 79:7492-502

Showing the most recent 10 out of 42 publications